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Background: In mammals, ABCB1 constitutes a cellular “first line of defense” against a wide array of chemicals and
drugs conferring cellular multidrug or multixenobiotic resistance (MDR/MXR). We tested the hypothesis that an
ABCB1 ortholog serves as protection for the sensitive developmental processes in zebrafish embryos against
adverse compounds dissolved in the water.
Results: Indication for ABCB1-type efflux counteracting the accumulation of chemicals in zebrafish embryos comes
from experiments with fluorescent and toxic transporter substrates and inhibitors. With inhibitors present, levels of
fluorescent dyes in embryo tissue and sensitivity of embryos to toxic substrates were generally elevated. We verified
two predicted sequences from zebrafish, previously annotated as abcb1, by cloning; our synteny analyses, however,
identified them as abcb4 and abcb5, respectively. The abcb1 gene is absent in the zebrafish genome and we
explored whether instead Abcb4 and/or Abcb5 show toxicant defense properties. Quantitative real-time polymerase
chain reaction (qPCR) analyses showed the presence of transcripts of both genes throughout the first 48 hours of
zebrafish development. Similar to transporter inhibitors, morpholino knock-down of Abcb4 increased accumulation
of fluorescent substrates in embryo tissue and sensitivity of embryos toward toxic compounds. In contrast,
morpholino knock-down of Abcb5 did not exert this effect. ATPase assays with recombinant protein obtained with
the baculovirus expression system confirmed that dye and toxic compounds act as substrates of zebrafish Abcb4
and inhibitors block its function. The compounds tested comprised model substrates of human ABCB1, namely the
fluorescent dyes rhodamine B and calcein-am and the toxic compounds vinblastine, vincristine and doxorubicin;
cyclosporin A, PSC833, MK571 and verapamil were applied as inhibitors. Additionally, tests were performed with
ecotoxicologically relevant compounds: phenanthrene (a polycyclic aromatic hydrocarbon) and galaxolide and
tonalide (two polycyclic musks).
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Conclusions: We show that zebrafish Abcb4 is a cellular toxicant transporter and provides protection of embryos
against toxic chemicals dissolved in the water. Zebrafish Abcb4 thus is functionally similar to mammalian ABCB1,
but differs from mammalian ABCB4, which is not involved in cellular resistance to chemicals but specifically
transports phospholipids in the liver. Our data have important implications: Abcb4 could affect bioavailability - and
thus toxicologic and pharmacologic potency - of chemicals to zebrafish embryos and inhibition of Abcb4 therefore
causes chemosensitization, that is, enhanced sensitivity of embryos to toxicants. These aspects should be
considered in (eco)toxicologic and pharmacologic chemical screens with the zebrafish embryo, a major vertebrate
model.
Keywords: Abcb4, Abcb5, Chemosensitization, Efflux transporters, Environment-tissue barrier, Multixenobiotic
resistance, MXR, P-glycoproteinBackground
ATP-binding cassette (ABC) transporters are one of the
largest membrane protein super-families and are present
in all biota from prokaryotes to mammals. They play a
fundamental role in the transport of exogenous and en-
dogenous compounds across inter- and intracellular
boundaries. Malfunction of certain members of the ABC
family causes various diseases, such as Tangier disease,
cystic fibrosis and Dubin-Johnson syndrome [1]. Among
transporters that lower the cellular load of various toxi-
cants and drugs and thus maintain physiological integ-
rity is ABCB1a or P-glycoprotein, the best studied ABC
transporter thus far. It confers so-called multidrug resist-
ance (MDR) by diverting a range of drugs away from
their site of pharmacologic action, a central concern in
drug design for cancer therapy. On the other hand,
ABCB1-like activity that was found in a wide range of
organisms provides protection from toxicants, granting
so-called multixenobiotic resistance (MXR) [2]. Indeed,
knock-out of Abcb1 in mice led to an increased perme-
ability of the blood–brain barrier for neurotoxic com-
pounds, allowing for enhanced brain penetration and
lethal effects [3]. Moreover, occurrence of aquatic spe-
cies in polluted environments is linked to high expres-
sion and increased efflux activity of Abcb1 orthologs [4],
which are constituents of the transporter-mediated “en-
vironment-tissue barrier” [5]. In fact, mammalian
ABCB1 is regarded as the only ABC transporter that has
no physiological function other than protection of cells
against a wide range of chemicals [6]. In contrast, two
other ABC transporters that are structurally highly simi-
lar to ABCB1, ABCB4 and ABCB5, appear not to be in-
volved in cellular protection against toxicants. ABCB4
has a specific physiological function in the liver and
transports only particular compounds [7,8]. Over-
expression of ABCB5 in certain cancer cells is associated
with multidrug resistance [9], but it may not provide
toxicant protection to cells in its normal function.
Ex utero embryo development is common among
aquatic organisms and requires cellular adaptationsaffording explicit robustness and protection against ad-
verse environmental impacts. These “orphan” embryos
are literally flooded with a multitude of natural and
man-made chemicals and efflux transporter proteins ap-
pear to form a primary defense mechanism that keeps
these compounds out [10]. For instance, embryos of the
echiuroid worm, Urechis caupo, which develop in mud-
flats containing metabolic products of bacteria and plants,
showed high levels of ABCB1-like efflux activity [11].
The zebrafish (Danio rerio) embryo has emerged as a
valuable vertebrate model in diverse fields, such as gen-
etics and human disease, pharmacology and (eco)toxi-
cology [12]. While it represents the most diverse group
of vertebrates - fishes - it also offers the exquisiteness of
fast development, access to genetic manipulation, com-
parability of organogenesis to higher vertebrates and
transparency, along with suitability for high-throughput
screening. For example, 309 chemicals were evaluated
for potential human health and ecological effects as part
of the U.S. Environmental Protection Agency’s (EPA’s)
ToxCast™ phase-I program ([13]; [14]) and thousands of
chemicals were screened to identify novel neuroactive
drugs in a high-throughput behavioral assay with
zebrafish embryos [15]. Moreover, developments are un-
derway to establish the zebrafish embryo for rapid evalu-
ation of the toxicity and bioaccumulation potential of
the thousands of chemicals undergoing environmental
risk assessment instead of relying on juvenile and adult
fish [16]. The role of ABC transporters in the zebrafish
developmental processes and in dealing with chemical
exposure is, however, as yet unknown, and uptake and
distribution of chemicals are generally assumed to be
driven by passive diffusion.
We here demonstrate that the uptake of chemicals by
zebrafish embryos can in fact be substantially influenced
by ABC transporter activity. Throughout the first 48
hours of development, zebrafish embryos exhibit activ-
ity of an ABCB1-like efflux. Surprisingly, however, an
abcb1 ortholog appears to be absent in zebrafish. We
found gene expression of abcb4 and abcb5 in zebrafish
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Abcb1 and we show that Abcb4, but not Abcb5, protein
possesses functional properties of mammalian ABCB1,
constituting an active barrier against chemical uptake and
conferring resistance of embryos to ABCB1 substrates.Results and discussion
P-glycoproteins in zebrafish are abcb4 and abcb5
orthologs
Three structurally similar proteins, ABCB1, ABCB4 and
ABCB5, are considered as “P-glycoproteins”. The zebrafish
possesses only two P-glycoprotein genes that, being anno-
tated as abcb1 orthologs, were previously designated
abcb1a and abcb1b; abcb4 and abcb5 were considered ab-
sent [17]. We confirmed the predicted cDNA sequences
of both genes by cloning. Nucleotide sequence identity of
the cDNAs is 59% and the deduced amino acid sequences
show 50 to 64% identities with human ABCB1, ABCB4
and ABCB5 (Additional file 1: Table S1).Figure 1 Synteny and phylogenetic analysis of zebrafish abcb4/Abcb4
green spotted puffer (Tetraodon nigroviridis) and human (Homo sapiens) ab
ABCB4 region is syntenic to zebrafish and green spotted puffer. The human
however, green spotted puffer lacks a abcb5 ortholog. B) The phylogenetic
Abcb5 and Abcb11 amino acid sequences from Danio rerio and other verte
and the percentage concordance based on 1,000 bootstrap iterations is sh
listed in Additional file 1: Table S2.According to current annotations on the ensembl
database [18] former abcb1a is designated abcb5
(ENSDARG00000021787) and former abcb1b is abcb4
(ENSDARG00000010936); an Abcb1 ortholog is absent.
Our synteny analyses of the respective chromosomal lo-
calizations of the genes in zebrafish are in line with the
ensembl annotations and support that the zebrafish P-
glycoproteins are not abcb1 orthologs. Human ABCB1
and ABCB4 are consecutively located, whereas in
zebrafish there is only one P-glycoprotein in a corre-
sponding chromosome region. This gene is in close
proximity to crot, resembling human ABCB4 and CROT
(Figure 1A). Furthermore, genes characteristic for the
close vicinity of human and other vertebrate Abcb1
genes, comprising rundc3b, slc25a40 and adam22, are
located approximately 14 megabases (Mb) away from
this locus in zebrafish. In concordance with zebrafish,
other fish species (Latimeria chalumnae, Gasterosteus
aculeatus, Oryzias latipes, Gadus morhua) also possess
only abcb4, but not abcb1 (Additional file 1: Figure S1),and abcb5/Abcb5. A) Conserved synteny of zebrafish (Danio rerio),
cb1/ABCB1, abcb4/ABCB4 and abcb5/ABCB5 regions. The human ABCB1/
ABCB5 region is syntenic to zebrafish and green spotted puffer;
tree based on the multiple alignments (Clustal X2) of Abcb1, Abcb4,
brates. The tree was generated using the neighbor-joining method
own at the nodes. Protein accession nos. (Ensembl or GenBank) are
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have both abcb1 and abcb4 (Figure 1A, Additional file 1:
Figure S1). Analysis of the abcb1a/abcb5 chromosomal
localization indicates that zebrafish abcb1a is an abcb5
ortholog. This chromosomal region of abcb5 shares syn-
teny with human ABCB5 (Figure 1A), indicating that
this locus has a common ancestral origin. Zebrafish
Abcb1a/Abcb5 protein also associates with Abcb5
orthologs from other organisms in a phylogenetic tree
(Figure 1B).
In this tree, proteins from different fish species desig-
nated as “Abcb4”, “Abcb1”, “Mdr1” or “P-glycoprotein”
group to a cluster of fish P-glycoproteins that show close
relationship with tetrapod ABCB1 and ABCB4 (Figure 1B).
This suggests that tetrapod and teleost ABCB1/Abcb1 and
ABCB4/Abcb4 have a common ancestor. Mammalian
ABCB1 and ABCB4 sequences are highly similar but the
functions of the proteins largely differ. Whereas substrate
recognition of ABCB1 is rather unspecific, enabling it to
act as a versatile efflux pump of toxicants, ABCB4 is a
highly specialized transporter that trans-locates certain
phospholipids and does not efflux toxicants from cells [7].
Differences in function despite the high sequence similar-
ity of ABCB1 and ABCB4 raise the question if functional
properties of the closely related fish P-glycoproteins are
ABCB1- or ABCB4-like and if they are toxicant trans-
porters. Further, the ability of human ABCB5 to confer
multidrug resistance of cancer cells [9] may suggest that
the zebrafish Abcb5 ortholog may act as a cellular efflux
pump of toxicants.
The absence of an abcb1 ortholog contradicted detec-
tion of an ABCB1-like efflux activity and multixenobiotic
resistance of zebrafish embryos (see below). We, hence,
investigated whether instead the other P-glycoproteins,
Abcb4 and Abcb5, act as toxicant transporters.
Abcb4 and abcb5 transcripts are constitutively expressed
during the first 48 hours of zebrafish embryo
development
We examined constitutive expression levels of abcb4
and abcb5 transcripts in zebrafish embryos from 1 to 48
hpf (hours post fertilization) for determining if these
genes are transcribed and thus are candidates to be in-
volved in cellular toxicant defense in these stages. Tran-
scripts of both transporters were present at all sampledTable 1 Relative abcb4 and abcb5 mRNA abundances in zebra
hpf 1 6
abcb4 57.09 ± 13.03 2.36 ± 0.91
abcb5 11.81 ± 1.87 2.05 ± 0.74
β-actin 20,575 ± 572 15,613 ± 6,938
The mRNA abundances were determined in embryos at 1, 6, 12, 24 and 48 hours p
are shown as means ± SD of four independent RNA isolations. Expression values we
exemplarily shown for a highly expressed gene for comparison.time points of development (1, 6, 12, 24, 48 hpf)
(Table 1). Abcb4 and abcb5 transcript levels varied one
to two orders of magnitude among developmental
stages, but expression was generally low in comparison
to, for example, β-actin with transcript levels that were
three to four orders of magnitude higher. From the dif-
ferent embryonic stages considered transporter tran-
script levels of both transporters were highest at 1 hpf;
abcb4 was lowest at 12 hpf, increasing from there on;
abcb5 levels varied from stage to stage (Table 1). Tran-
scripts in 1 and 6 hpf embryos are maternally transferred
mRNA as de novo transcription is initiated between
mid-blastula (1 k-cell stage: 3 hpf ) and gastrula stages
(75% epiboly; 7 hpf) [19].
Whole-mount in situ hybridization (WISH) revealed
ubiquitous, weak constitutive abcb4 expression in the
developmental period of zebrafish embryos examined
here, which is indicated by faint purple staining of the
entire embryos at the examined stages (Figure 2). Speci-
ficity of the probe we used was confirmed with 120 hpf
embryos where a strong WISH signal occurred in the
gut (Additional file 1: Figure S3). When assuming that
transcript levels are indicative of protein expression and
activity, the ubiquitous expression of abcb4 transcripts
found in 18 and 36 hpf embryos suggests a general con-
tinuous Abcb4 activity in all embryonic cells in this de-
velopmental phase.
Expression of abcb5 transcripts has been found in epi-
dermal cells of zebrafish embryos [20], which could
point to a similar function of the protein as in mammals
where it regulates membrane potential and cell fusion of
skin progenitor cells [21].
Abcb4 but not Abcb5 antagonizes accumulation of
fluorescent transporter substrates in zebrafish embryos
Having shown that abcb4 and abcb5 transcripts are
present in zebrafish embryos, we examined the function
of the corresponding proteins as efflux pumps. Rhoda-
mine B and calcein-am served as proxies for efflux
transporter activity. Efflux transporter activity is indi-
cated when the accumulation of fluorescent dye sub-
strates is increased in cells due to disrupted transporter
activity and, hence, disrupted active efflux of dye by
transporter inhibiting chemicals [22] or by knock-down
of the transporter protein.fish embryos at different developmental stages
12 24 48
0.91 ± 0.26 2.03 ± 0.31 11.62 ± 0.99
7.81 ± 0.74 2.36 ± 1.19 0.614 ± 0.09
24,639 ± 9,007 17,740 ± 3,948 22,004 ± 6,891
ost fertilization (hpf). The expression levels that were normalized to 18S rRNA
re multiplied by 106 for clarity of presentation. Beta-actin transcript levels are
Figure 2 Images of 18 hpf (A) and 36 hpf (B) zebrafish embryos
showing abcb4 expression patterns. Abcb4 transcripts where
visualized with whole mount in situ hybridization. The faint but
global staining patterns indicate weak, ubiquitous constitutive
expression of abcb4 in the embryos at both stages.
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rhodamine B and calcein-am/calcein in tissues of zebrafish
embryos
We measured changes in uptake of these dyes by em-
bryos in the presence of two pharmacologic inhibitors of
mammalian P-glycoproteins, namely cyclosporin A [23]
and PSC833 [24], and of MK571, an inhibitor of mam-
malian ABCC transporters [25]. Fluorescence micro-
graphs of embryos show that rhodamine B accumulatedFigure 3 Fluorescence micrographs of 48 hpf zebrafish embryos that
am either in the presence of different ABC transporter inhibitors (A) o
inhibitor compounds were cyclosporin A (CsA), PSC833 and MK571. Morph
MO/Abcb4-ATG-MO) or Abcb5 (Abcb5-SP-MO). Exposure water of control e
(ctrl-MO) served to exclude unspecific morpholino effects on dye accumula
accumulation of higher amounts of dye in the embryo tissue.mainly in the yolk sac, whereas calcein fluorescence
appeared in the head, trunk and cells scattered in the
embryo body surface (Figure 3). Calcein-am is non-
fluorescent, but once inside cells, it is hydrolyzed by
cytosolic esterases and forms green, fluorescent calcein.
Thus, calcein fluorescence in addition to efflux trans-
porter activity also depends on the rate of calcein forma-
tion by esterases. Rhodamine B, on the other hand, is
already fluorescent without modification in the cell and
these differences may explain the differing spatial accu-
mulation patterns of the dyes in embryo tissues. Fluores-
cence intensities of both dyes were increased when
cyclosporin A, PSC833 or MK571 (Figure 3A) was also
present, indicating elevated dye accumulation in the em-
bryos. Thus, without an inhibitor, the accumulation of
dyes in the embryos is kept low, evidencing that both
rhodamine B and calcein-am are kept out of embryo tis-
sues by an active efflux mechanism.
For quantifying amounts of accumulated dye in em-
bryos of different developmental stages, we measured
rhodamine B levels in embryo tissue extracts followinghad been incubated with 0.5 μM rhodamine B or 1.0 μM calcein-
r upon knock-down of Abcb4 or Abcb5 (B). ABC transporter
olino oligonucelotides were used for knock-down of Abcb4 (Abcb4-SP-
mbryos contained dye only (ctrl, ctrl-MO). The morpholino control
tion in the embryos. Brighter appearing embryos indicate
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embryo in controls, indicating the basal accumulation of
the dye in the embryos with efflux transporters function-
ing, were approximately 200 fmol at 1 hpf, increasing to
approximately 350 fmol at 6 hpf, 12 hpf and at 24 hpf
and approximately 400 fmol at 48 hpf (Figure 4A,
Additional file 1: Table S3). Enhanced accumulation of
dye with the inhibitors cyclosporin A, PSC833 andFigure 4 Quantification of rhodamine B (RhB) dye accumulation in ze
hpf, 24 hpf and 48 hpf zebrafish embryos that, simultaneously to RhB, were
cyclosporin A (CsA), PSC833 or MK571. (B) Amounts of RhB accumulated in
(Abcb4-SP-MO/Abcb4-ATG-MO) or Abcb5 (Abcb5-SP-MO). Controls contain
exclude unspecific morpholino effects on dye accumulation in the embryo
as comparisons for the effects of this pharmacologic transporter inhibitor o
deviations from three independent experiments. Statistically significant diff
variance (ANOVA), followed by Dunnett’s test and are indicated by asterisksMK571 was seen in embryos of all tested developmental
stages, which demonstrates efflux transporter activities
in all those stages. Rhodamine B tissue levels were ele-
vated with increasing inhibitor concentrations and were
up to 1.8- to 3.25-fold higher compared to controls
(Figures 4A, Additional file 1: Table S3). For example,
at 10 μM cyclosporin A or 10 μM PSC833, amounts of
rhodamine B per embryo at 48 hpf were approximatelybrafish embryos. (A) Amounts of RhB accumulated in 1 hpf, 6 hpf, 12
exposed to various concentrations of transporter inhibitors
48 hpf zebrafish embryos upon morpholino knock-down of Abcb4
ed dye only (ctrl, ctrl-MO), the morpholino control (ctrl-MO) served to
s. Experiments with CsA (5 μM CsA, ctrl-MO + 5 μM CsA) were set up
n RhB accumulation in the embryos. Values are means +/− standard
erences from controls were determined with one-way analysis of
(P <0.05).
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MK571 also increased dye accumulation in the embryos,
but it was less potent than cyclosporin A and PSC833.
Thus, at 10 μM MK571, rhodamine B amounted to ap-
proximately 700 fmol per 48 hpf embryo.
Effects of morpholino knock-down of Abcb4 and/or Abcb5
on accumulation of rhodamine B and calcein-am/calcein in
tissues of zebrafish embryos
We examined whether Abcb4 and/or Abcb5 mediate
cellular efflux activity in the embryos with morpholino
knock-down. We used splice-blocking morpholinos for
knock-down of Abcb4 (Abcb4-SP-MO, 0.5 mM) and
Abcb5 (Abcb5-SP-MO, 0.5 mM) proteins, respectively,
and assayed rhodamine B and calcein-am uptake by
those embryos at 48 hpf. Control morpholino-treated
embryos (Crtl-MO, 1 mM) served as the control for un-
specific effects of morpholino injection on dye uptake.
Abcb4 and Abcb5 knock-down did not cause phenotypic
or necrotic effects, indicating that both Abcb4 and
Abcb5 are not essential for development or basic physio-
logical homeostasis in embryos up to 48 hpf. This is
reminiscent of Abcb1 knock-out mice that also develop
normally [3]. In the dye assays, rhodamine B and calcein
fluorescence were brighter upon Abcb4 knock-down
compared to the control, whereas Abcb5 knock-down
had no visible effect on dye uptake (Figure 3B). Upon
Abcb4 knock-down, approximately 650 fmol rhodamine
B accumulated per 48 hpf embryo compared to ap-
proximately 450 fmol and approximately 400 fmol in
Abcb5 knock-down and control morpholino treated
embryos, respectively (Figure 4B). Abcb4 knock-down
with a translation-blocking morpholino (Abcb4-ATG-
MO, 0.0625 mM) resulted in accumulation of approxi-
mately 650 fmol rhodamine B per embryo, which is
similar to the effect of the Abcb4 splice-blocking
morpholino (Figures 3B and 4B). These results show
that changes in rhodamine B or calcein accumulation
were specifically related to Abcb4 knock-down. Thus,
Abcb4, but not Abcb5, appears to act as an efflux pump
of rhodamine B and calcein-am, respectively, keeping
tissue concentrations of these compounds in zebrafish
embryos low.
From these data, efflux of rhodamine B can clearly be
associated with Abcb4 activity; however, the effect of
Abcb4 knock-down on rhodamine B accumulation in
the embryos was not as pronounced as with high cyclo-
sporin A and PSC833 concentrations (Figure 4A). The
reason for this discrepancy of Abcb4 knock-down and
inhibitor effects could be that morpholino knock-down
does not result in complete suppression of Abcb4 pro-
tein function. Thus, morpholino treatment that leads to
transient knock-down of correct pre-mRNA splicing or
mRNA translation does not necessarily result incomplete elimination of functional protein; thus, to a
certain extent, functional Abcb4 may still have been
present in Abcb4 knock-down embryos. Rhodamine B
efflux could, apart from Abcb4, be mediated also by
other transporters that remain functional in Abcb4
knock-down embryos, but are blocked by chemical in-
hibitors. There is, for example, indications that cyclo-
sporin A and PSC833, apart from Abcb, also block
activity of Abcc transporters of fish [26]. In addition to
Abcb4, Abcc transporters that have earlier been shown
to be expressed in zebrafish embryos [27] may play a
role in rhodamine B efflux. However, our data indicate
that the role of Abcc transporters in efflux of rhodamine
B is minor: MK571, an inhibitor of mammalian ABCCs,
has a comparatively small effect on rhodamine B efflux
(Figures 3A and 4A). In addition, the MK571 effect on
rhodamine B accumulation may in fact be Abcb4 inhib-
ition as is indicated by our tests with MK571 and re-
combinant Abcb4 (Figure 5E, see below). These results
thus support that rhodamine B efflux in zebrafish em-
bryos is majorly mediated by Abcb4 and that Abcb4
knock-down does not completely disrupt Abcb4
function.
Effects of other chemicals on rhodamine B efflux in
zebrafish embryos
Galaxolide, tonalide, phenanthrene, verapamil and vin-
blastine also caused increased accumulation of rhoda-
mine B in 48 hpf zebrafish embryos in a concentration-
dependent manner (Figure 6, Additional file 1: Table S3).
The data confirm interaction of those compounds with
the rhodamine B efflux mechanism in zebrafish embryos
that, as we show here, is Abcb4. Levels of rhodamine B
in embryo tissue were significantly increased in zebrafish
embryo tissue at concentrations ≥0.1 μM tonalide, ≥1 μM
phenanthrene and galaxolide, and ≥2.5 μM verapamil
and vinblastine (Figure 6, Additional file 1: Table S3).
Galaxolide, tonalide and phenanthrene, which were in-
cluded in the tests as ecotoxicologically relevant
chemicals, were as effective as the inhibitors cyclo-
sporin A and PSC833 causing accumulation of approxi-
mately 1,100 to 1,500 fmol rhodamine B per embryo,
equivalent to 2.4- to 2.9-fold increases compared to the
controls. Galaxolide and tonalide, polycyclic musk
compounds, have earlier been found to act as efflux
transporter inhibiting chemosensitizers in marine bi-
valves [30]; the data in this study indicate that the
musks also affect the efflux of rhodamine B in
zebrafish embryos, which appears to be conferred by
Abcb4 (Figure 5J-K, see below). The effect of verapamil, a
potent inhibitor of mammalian ABCB1, was not as high
as was found with the other ABCB1 inhibitors, cyclo-
sporin A and PSC833. The amount of rhodamine B was
maximally 860 fmol per embryo, corresponding to a 1.9-
Figure 5 Effects of chemicals on ATPase activities of recombinant zebrafish Abcb4. Compounds were tested for stimulation (open squares)
of Abcb4 ATPase and inhibition of the verapamil-stimulated Abcb4 ATPase activities (closed circles). Tested compounds were verapamil (A),
calcein-am (B), rhodamine B (C), cyclosporin A (D), MK571 (E), PSC833 (F), vinblastine (G), vincristine (H), doxorubicin (I), tonalide (J), galaxolide
(K) and phenanthrene (L). Values are means +/− SEM from three to four independent experiments. Means and SEM ranges of the baseline (bl)
and with 40 μM verapamil maximally stimulated ATPase activities (ms) are indicated as horizontal dotted lines. Regression curves for ATPase
stimulation were fitted using a modified Michaelis-Menten equation {VS = (K1K2V0 + K2V1S + V2S
2)/(K1K2 + K2S + S
2) [28,29]}; regression curves for
inhibition of the stimulated ATPase activities were fitted to a modified version of this equation describing the descending part of the curve {VS =
V1 + ((V2X)/(K2 + X))}. Statistically significant effects on ATPase stimulation or inhibition of stimulated ATPase activities were identified by
comparison of data with baseline and maximally stimulated ATPase activities, respectively, using one-way analysis of variance (ANOVA), followed
by Dunnett’s test and are indicated by asterisks (*: P <0.05) below the baseline line (different from baseline activity - significant stimulation) or
above the line of maximal stimulation (different from the maximally stimulated activity - significant inhibition).
Fischer et al. BMC Biology 2013, 11:69 Page 8 of 16
http://www.biomedcentral.com/1741-7007/11/69fold increase of rhodamine B accumulated in embryos with
verapamil present (Figure 6, Additional file 1: Table S3).
Interestingly, however, our assays with recombinant
protein indicated strong interaction of verapamil with
Abcb4 from zebrafish, suggesting that verapamil acts as
a substrate of this transporter (Figure 5A, see below).
Being a substrate of the efflux transporter, verapamilmay cause competitive inhibition of the transporter
function and, therefore, its inhibitory potency depends
on the degree of interference with another substrate (in
our case rhodamine B) when both bind to the substrate
binding site of the protein. Thus, interference can
be low if two compounds bind to different sites of
the substrate binding site [31]. The discrepancy of
Figure 6 Amounts of rhodamine B (RhB) accumulated in 48 hpf zebrafish embryos when also exposed to different concentrations of
various chemicals. These compounds comprised the synthetic musk fragrances galaxolide and tonalide, the polycyclic aromatic hydrocarbon
phenanthrene, the ABCB1 inhibitor verapamil and the ABCB1 substrate vinblastine. Galaxolide, tonalide and phenanthrene are ecotoxicologically
relevant chemicals. Embryos were exposed to RhB and simultaneously to either of these compounds. Values are means +/− standard deviations
from three independent experiments. Statistically significant differences from controls were determined with one-way analysis of variance
(ANOVA), followed by Dunnett’s test and are indicated by asterisks (P <0.05).
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and strong interaction with the transporter protein
ATPase by verapamil could thus be explained with little
interference of the compounds when binding to the
Abcb4 binding site. All of the tested compounds
interacted with recombinant Abcb4 in the ATPase assay
(Figure 5; see below) suggesting that their effect on
rhodamine B accumulation in the embryos is associated
with inhibition of the Abcb4-mediated efflux activity of
rhodamine B.
Disruption of Abcb4 activity leads to increased sensitivity
of embryos to toxic transporter substrates
Effects of ABC transporter inhibitors on the mortality of
embryos due to toxic compounds
We chose vinblastine, vincristine and doxorubicin, cyto-
toxic substrates of human ABCB1 [32-34], and phenan-
threne as an ecotoxicologically relevant model compound,
for determining to what extent chemical resistance of
zebrafish embryos is associated with ABC transporter ef-
flux activity. In initial experiments that served to deter-
mine concentrations of the compounds that were toxic to
zebrafish embryos we focused on the micromolar concen-
tration range in which interaction of chemicals with trans-
porters is generally observed. When embryos were
exposed to the compounds from 1 to 48 hpf, we found le-
thal effects of vinblastine at concentrations >1 μM and
100% mortality at concentrations ≥5 μM; of vincristine
at concentrations ≥10 μM; and of phenanthrene at con-
centrations >1 μM and 100% mortality at concentra-
tions ≥20 μM. Within the concentration range tested
(up to 40 μM), vincristine did not cause 100% mortality.
Toxicity of doxorubicin for zebrafish embryos appears
to be low; we found no toxic effects for the compoundat concentrations in the micromolar range and, indeed,
lethal effects were reported for substantially higher
concentrations [35].
In further experiments that served to explore the role
of transporter activity for the sensitivity of zebrafish em-
bryos to toxic compounds, the test compounds were ap-
plied in a concentration series with two concentrations
of vincristine (20, 40 μM) that were found to be toxic
and for vinblastine and phenanthrene within the range
causing up to 100% mortality in zebrafish embryos;
doxorubicin was not further considered in these experi-
ments. Toxicities of vinblastine, vincristine and phenan-
threne were compared when applied alone and in
combination with the non-toxic concentration of 5 μM
of the transporter inhibitor cyclosporin A and, in the
case of vinblastine, as well with 5 μM PSC833.
In an experimental series with vinblastine and cyclo-
sporin A, LC50 values (concentration that was lethal for
50% of embryos) for vinblastine after exposure from 1 to
48 hpf were 3.05 μM (95% CI (confidence interval):
2.94 to 3.17 μM) without and 2.37 μM (95% CI: 2.25 to
2.49 μM) with cyclosporin A (Figure 7A), which is a
difference of 22.3% (Additional file 1: Table S4). A simi-
lar decrease in LC50 for vinblastine was seen with
PSC833 (Figure 7B) indicating higher toxicity of vin-
blastine when the transporter inhibitors were present.
For testing whether the increase in vinblastine toxicity
was indeed due to higher accumulations of the com-
pound in the embryos, we studied uptake of bodipy-
labeled, fluorescent vinblastine by embryos. Fluores-
cence intensities were elevated in embryos treated with
1.0 μM bodipy-vinblastine combined with cyclosporin
A compared to embryos exposed to bodipy-vinblastine
only (Figure 8A). This indicates that accumulation of
Figure 7 Percent mortalities of zebrafish embryos after 1 to 48
hpf exposures to toxic compounds in the presence or absence
of ABC transporter inhibitors. The graphs show mortalities caused
by different concentrations of vinblastine without and with 5 μM
CsA (A) or 5 μM PSC833 (B) and of phenanthrene (C) and of
vincristine (D) without and with 5 μM CsA. Depicted are mean
values and standard deviations of independent replicates. For
vinblastine and phenanthrene concentration-response regressions
were determined using the logistic HILL model with bottom
restrained to 0 and top restrained to 100. The dotted lines indicate
the concentration causing mortality in 50% of the embryos (LC50).
Refer to Additional file 1: Table S3 for details on the number of
independent replicates, LC50 values with confidence intervals and
further curve parameters. Statistically significant differences in
mortalities between treatments without and with inhibitors at
respective vinblastine, vincristine or phenanthrene concentrations
were determined with the paired (vinblastine, vincristine) or the
regular t-test (phenanthrene) and are indicated by asterisks (P <0.05).
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transporter activity and confirms that higher vinblastine
toxicity in the presence of inhibitors is due to reduced
efflux and thus increased accumulation of the com-
pound in the embryos.
As found for vinblastine, mortalities of embryos were
significantly increased when vincristine and phenanthrene,
respectively, were combined with 5 μM cyclosporin A,
likewise indicating higher accumulation of those com-
pounds in the embryos when cellular efflux activity is
blocked (Figures 7C, D). Mortalities caused by 10 and 20
μM vincristine were increased by 3.5- and 1.3-fold when
cyclosporine was also present (Figure 7D). Cyclosporin A
had a significant effect on the toxicity of phenanthrene,
evidenced by a 37% difference between the LC50 values
for phenanthrene alone (3.8 μM) and with cyclosporine
(2.4 μM) (Figure 7C, Additional file 1: Table S3).
Effects of morpholino knock-down of Abcb4 or Abcb5 on
vinblastine-caused mortalities in embryos
We furthermore examined the effect of disruption of
transporter activity on resistance of embryos to vinblast-
ine using morpholino knock-down. After 48 hours, ex-
posure to 2 μM vinblastine caused 74% ± 10.2 mortality
in embryos upon knock-down of Abcb4, whereas Abcb5
knock-down and control morpholino embryos showed
mortalities (53% ± 10.6 and 50% ± 12.3, respectively) simi-
lar to untreated controls (ctrl; 44% ± 13.2 ) (Figure 8B). As
with the Abcb4 splice-blocking morpholino treated em-
bryos, elevated sensitivity to vinblastine was also found for
embryos treated with the Abcb4 translation-blocking
morpholino (Figure 8B). The experiments with bodipy-
vinblastine support the interpretation that stronger effects
by vinblastine upon Abcb4 knock-down are associated
with increased vinblastine accumulation in the embryos.
Thus, as with cyclosporin A, the bodipy-vinblastine fluor-
escence in embryos was likewise increased when Abcb4
knock-down embryos (Figure 8A). When non-morpholino,
control morpholino or Abcb5 knock-down embryos were
co-treated with cyclosporin A or PSC833, mortalities by
2 μM vinblastine were raised to similar levels as those
in embryos with Abcb4 knock-down without an inhibitor.
The similar effects of Abcb4 knock-down and of trans-
porter inhibitor compounds indicate that Abcb4 has a
major role in mitigating vinblastine toxicity in zebrafish
embryos and that the sensitivity-enhancing effect of the
inhibitors, cyclosporin A and PSC833, is blocking activity
of this transporter. The effect in treatments with Abcb4
knock-down and inhibitors in combination tended to be
slightly stronger than in treatments with only Abcb4
knock-down or inhibitors (Figure 8B). This can be seen as
an indication that neither Abcb4 knock-down nor treat-
ment with the inhibitors at the concentration applied lead
to complete suppression of Abcb4 function, which is in
Figure 8 Effects of morpholino knock-down of Abcb4 or Abcb5 and of transporter inhibitors on accumulation of bodipy-vinblastine
and vinblastine-caused mortalities in zebrafish embryos. A) Fluorescence micrographs depicting 48 hpf zebrafish embryos that had been
incubated with bodipy-vinblastine either in combination with the inhibitor compound cyclosporin A (CsA) or upon knock-down of Abcb4
(Abcb4-SP-MO). The control was treated with dye only (ctrl), the morpholino control (ctrl-MO) served to exclude unspecific morpholino effects on
dye accumulation in the embryos. B) Mortalities of zebrafish embryos upon treatment with morpholino nucleotides for knock-down of Abcb4
(Abcb4-SP-MO/Abcb4-ATG-MO) or Abcb5 (Abcb5-SP-MO) that were not exposed to any chemical (no vinblastine) or exposed to 2 μM vinblastine
alone or in combination with 5 μM cyclosporin A (CsA) or 5 μM PSC833. Values are means +/− standard deviations from three to five
independent experiments. The control morpholino (ctrl-MO)/2 μM vinblastine treatment served as reference for determining whether changes in
mortality caused by 2 μM vinblastine were statistically significant when Abcb4 or Abcb5 were knocked-down or Abcb4 or Abcb5 knock-down
was combined with CsA or PSC833 treatments. Significant differences were identified using one-way analysis of variance (ANOVA), followed by
Dunnett’s test and are indicated by asterisks (P <0.05).
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mulation experiments (see above, Figure 4B).
Abcb4 substrates and inhibitors modulate the ATPase
activity of recombinant zebrafish Abcb4
Our results from the dye uptake and toxicological assays
indicate that (1) zebrafish embryos employ a multidrug
transporter like cellular efflux mechanism that blocks
uptake of chemicals by the embryos from the water and
thus mitigates their toxic effects; (2) this cellular efflux
of compounds is largely based on the activity of Abcb4,
but not of Abcb5; and (3) effects of transporter inhibi-
tors are associated with inhibition of Abcb4 activity.
Further evidence for interaction of the tested com-
pounds with Abcb4 as substrates and/or inhibitors
comes from assays where effects of chemicals on the
ATPase activity of recombinant Abcb4 protein were
quantified. As a measure for interaction of chemicals with
Abcb4, changes in ATPase activity of recombinant Abcb4
with the tested chemicals present were used (Figure 5).
Stimulation of the basal transporter ATPase activity, indi-
cated as the amount of inorganic phosphate (Pi) released
during the hydrolysis of ATP, occurs with compounds act-
ing as substrates; inhibition of the stimulated ATPase
activity is found for transporter inhibitors [36]. For stimu-
lation of Abcb4 in the inhibition experiment and as a posi-
tive control we used verapamil, which stimulated the
Abcb4 ATPase activity by 4.4-fold (mean of positive con-
trols from all experiments). The action of verapamil on
zebrafish Abcb4 is comparable to its effect on the human
ABCB1 ATPase activity, which is stimulated by 4.5- to
5.0-fold [36,37].Stimulation of the basal Abcb4 ATPase activity
The compounds that were applied as fluorescent (rhoda-
mine B, calcein-am) or toxic (vinblastine, vincristine,
phenanthrene) transporter substrates in experiments
with the zebrafish embryos generally stimulated the
basic Abcb4 ATPase activity (Figure 5B, C, G, H, L) al-
though the effect was statistically significant only for
calcein-am (Figure 5B). However, the Pi levels were gen-
erally above baseline also with rhodamine B, vinblastine,
vincristine and phenanthrene (Figure 5C, G, H, L),
which can be seen as an indication that these com-
pounds also stimulated the Abcb4 ATPase activity, albeit
to a lesser extent. Doxorubicin stimulates the ABCB1
ATPase activity only at very high concentrations [37]
and, accordingly, the compound had no effect on the
zebrafish Abcb4 ATPase activity in the concentration
range we tested (Figure 5I).
Apart from the classic ABCB1 inhibitor verapamil, the
other tested inhibitors, cyclosporin A and PSC833, sig-
nificantly and, in the case of MK571, weakly, stimulated
the Abcb4 ATPase activity (Figure 5D-F). The ATPase
stimulating effect of cyclosporin A is consistent with its
property as substrate of the mammalian ABCB1 [38],
even though, in contrast to our results with Abcb4, the
compound does not stimulate the ABCB1 ATPase [37].
Interestingly, substantial Abcb4 ATPase stimulation was
seen with tonalide and galaxolide, indicating their prop-
erties as Abcb4 substrates (Figure 5J, K). However, as
the compounds are very lipophilic [39], they probably
highly accumulate in the cellular membranes and it is,
therefore, questionable if Abcb4 activity leads to efflux
of the compounds from the cells.
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low micro-molar concentration range of compounds cor-
responding to the concentrations applied in the dye uptake
and toxicological assays with zebrafish embryos. This im-
plies that these concentrations were in a range where the
compounds are actively transported by Abcb4.
In the case of cyclosporin A, the concentration-
dependent Abcb4 ATPase activity showed an initial in-
crease in activity, followed by an activity decrease at higher
concentrations (Figure 5D). This biphasic response in
ATPase activities to increasing concentrations of a com-
pound is common for substrates of human ABCB1 and it is
associated with the presence of two binding sites with dif-
ferent binding affinities in the protein, one for stimulation
(with a high affinity that is activated at low concentrations)
and one for inhibition (with a low affinity that is activated
at higher concentrations) [28]. A decrease in ATPase stimu-
lation at higher concentrations was observed as a trend also
for MK571, vinblastine, galaxolide, tonalide and phenan-
threne (Figure 5E, G, J, K, L).
Inhibition of the stimulated Abcb4 ATPase activity
Except for rhodamine B (Figure 5C), all of the tested
compounds caused a decrease in the stimulated Abcb4
ATPase activity and the results are congruent with the
sensitizing effects of cyclosporin A and PSC833 in the
embryotoxicity tests (Figures 7 and 8) and with the ef-
fects of cyclosporine A, PSC833, MK571, vinblastine,
tonalide, galaxolide and phenanthrene on rhodamine B
accumulation in embryo tissue (Figures 3A, 4 and 6).
For MK571, which is an inhibitor of mammalian
ABCC1, the inhibiting effect indicates that it also acts
on zebrafish Abcb4 and, as discussed above, its effects
on rhodamine B accumulation in the zebrafish embryos
may in fact be from inhibition of Abcb4 in the embryos.
Conclusions
We here show that cellular efflux activity of an Abcb4
ortholog in zebrafish embryos in the first 48 hours of de-
velopment antagonizes uptake of chemicals from the
water. This is evidenced by the finding that the presence
of ABC transporter inhibitors as well as morpholino
knock-down of expression of functional Abcb4 leads to
increased accumulation of toxic and fluorescent trans-
porter substrates in the embryos. ATPase assays with re-
combinant zebrafish Abcb4 confirm the properties of
our test compounds as Abcb4 substrates and/or inhibi-
tors. Since morpholino knock-down of Abcb4 and expos-
ure of embryos to chemical transporter inhibitors had
similar effects on accumulation of substrates in the em-
bryos it can be concluded that zebrafish Abcb4 is a major
component of the MXR system of zebrafish embryos.
This multixenobiotic resistance mediating function of
the protein contrasts to mammalian ABCB4, which is aspecialized translocator of phosphatidylcholine (PC) into
bile that transports cytotoxic drugs only at low rates and
does not confer multixenobiotic resistance [8]. Contrary
to this, Abcb4 in fish may not act as a PC translocator
as is indicated by the lack of PC in the bile of the Asian
carp [40], which, like zebrafish, is a cyprinid. The ability
to transport a wide range of toxicants is probably a pri-
mary, ancient property of P-glycoproteins that is con-
served for Abcb4 in fish. This could explain why fish
tolerate the absence of Abcb1 since function as a toxi-
cant pump is executed by the Abcb4 ortholog. In adult
zebrafish, Abcb1-like efflux activity has been found to be
a component of the blood-brain barrier [41]. As Abcb1
is absent in zebrafish, this efflux activity may well be as-
sociated with the function of the Abcb4 ortholog.
Abcb5, the other P-glycoprotein in zebrafish, appears
not to mediate xenobiotic resistance.
The Abcb4-mediated efflux activity of toxicants in
zebrafish embryos, a major pharmacologic and toxicologic
model system, has important implications: 1) Abcb4 acti-
vity can substantially determine bioavailability - and thus
pharmacologic and toxicologic potency - of a diverse array
of chemicals to zebrafish embryos; 2) chemicals that
modulate Abcb4 activity, such as the chemical transporter
inhibitors we used, will enhance bioavailability of chemi-
cals to zebrafish embryos that are usually effluxed by
Abcb4. This chemosensitization by efflux transporter in-
hibition can be caused by a variety of chemicals, including
seemingly innocuous ones [42]. The polycyclic musk com-
pounds galaxolide and tonalide are an example for such
compounds as they do not exert obvious toxic effects on
zebrafish embryo development [43], but they clearly act as
potent Abcb4 inhibitors. Our data underscore that efflux
transporters are underappreciated but are important deter-
minants of bioavailability of chemicals to cells and organ-
isms. On the other hand, chemicals can reverse transporter
function and thus increase bioavailability of other com-
pounds. Depending on efflux transporter interference with
different compounds, bioavailability of compounds in a mix-
ture can deviate from that of the same components when
they are present alone. This suggests that current regula-
tory practice of assessing risks based on individual com-
pounds may underestimate toxicity. In this context, our
baculovirus-based Abcb4 activity assay has proven reliable
to determine substrate/inhibitor properties of test compounds
and will be useful in chemical screens using zebrafish.
Methods
Chemicals
Cyclosporin A, doxorubicin hydrochloride, phenanthrene,
rhodamine B, verapamil hydrochloride and vincristine sul-
fate were from Sigma-Aldrich (Schnelldorf, Germany).
Calcein-acetoxymethylester (calcein-am), MK571 and
vinblastine sulfate were from Biozol (Eiching, Germany)
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Germany). PSC833 was a kind gift from Novartis (Basel,
Switzerland). Galaxolide (73% of the total are diasterimeric
isomers of 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl-
cyclopenta-γ-[2]-benzopyran) was a kind gift from Inter-
national Flavors & Fragrances Inc. (IFF; Union Beach, NJ,
USA) and Tonalide (7-acetyl-1,1,3,4,4,6-hexamethyl-
1,2,3,4-tetrahydronaphthalene; purity: 98%) was
obtained from Bush Boake Allen Inc. (Jacksonville, FL,
USA). RhB was dissolved in MilliQ water; stock solu-
tions of all other chemicals were prepared in dimethyl
sulfoxide (DMSO, Sigma-Aldrich). Final DMSO solu-
tions in exposure media did not exceed 0.2%.
Culture of zebrafish, collection of eggs and culture of
embryos
Adult zebrafish from the WIK wildtype strain were
maintained and bred according to standard protocols
[44]. Collection of eggs and culturing of the embryos
were performed as described [45].
RNA extraction and reverse transcription
Total RNA was extracted from 30 to 50 embryos from 1, 6,
12, 24 and 48 hpf zebrafish embryos using TRIzol Reagent
(Invitrogen) according to the manufacturer’s instructions.
Genomic DNA contaminations were removed with DNAse I
(Roche, Grenzach, Germany) treatment. cDNA was synthe-
sized from total RNA using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems, Darmstadt, Germany).
Cloning of zebrafish abcb4 and abcb5 cDNAs and
phylogenetic and synteny analysis
Zebrafish abcb4 (predicted sequence accession no.
ENSDARG00000010936) and abcb5 (predicted ENSDA
RG00000021787) sequences were obtained using reverse
transcription polymerase chain reaction (RT-PCR) with pri-
mer pairs designed either based on the predicted sequences
or based on sequences obtained with rapid amplification of
cDNA ends (RACE) (Clontech, Palo Alto, USA). For PCR,
Advantage 2 (Clontech) and Phusion (Finnzymes, Thermo-
fisher, Schwerte, Germany) polymerases were used. PCR
products were gel purified, cloned and sequenced on an
ABI 3100 sequencer (Applied Biosystems) using standard
cycle sequencing protocols. Sequences were edited and as-
sembled using Sequencher 4.9 (Genecodes, Ann Arbor,
USA) and analyzed using the National Center for Biotech-
nology Information (NCBI) basic alignment search tool
(BLAST) and the Expert Protein Analysis System (ExPASy,
Swiss Institute of Bioinformatics, Lausanne, Switzerland)
[46]. The zebrafish abcb4 and abcb5 sequences were sub-
mitted to GenBank (NCBI). Accession numbers are listed
in Additional file 1: Table S2.
Identity rates of zebrafish transporter nucleotide/amino
acid sequences with vertebrate orthologs were determinedwith ClustalX2 (Conway Institute UCD, Dublin, Ireland).
Phylogentic trees were generated with MEGA5 (Center for
Evolutionary Medicine and Informatics, Tempe, USA)
using the neighbor-joining method with percentage con-
cordance based on 1,000 bootstrap iterations. To establish
syntenic relationships between vertebrate genomes within
the chromosomal regions of interest, we made use of
ortholog predictions in the Ensembl database [18].
Quantification of mRNA expression levels in zebrafish
embryos
mRNA expression levels of abcb4 and abcb5 in 1, 6, 12, 24
and 48 hpf zebrafish embryos were quantified with quanti-
tative RT-PCR (qPCR) using the SYBR Green PCR Master
Mix (Quantace, Berlin, Germany). with an iCycler Real-
Time PCR Detection System (BioRad, Munich, Germany).
Primers for housekeeping and zebrafish ABC trans-
porter genes (Additional file 1: Table S5) were designed
against available mRNA sequences from Ensembl [18]
and self-obtained sequences using Beacon Designer (Pri-
mer Biosoft, Palo Alto, USA). Samples were run in tripli-
cate in optically clear 96-well plates (Biozym, Hessisch
Oldendorf, Germany). PCR was performed with RNA
extracts from three different zebrafish embryo batches.
qPCR results were calculated relative to the housekeep-
ing gene, 18S (for selection of the housekeeping gene
refer to Additional file 1: Figure S2), according to the
normalization procedure of the Q-Gene Core Module
[47-49], which takes varying PCR amplification efficien-
cies into account (Additional file 1: Table S6). All qPCR
experiments were performed according to the MIQE
(Minimum Information for Publication of Quantitative
Real-Time PCR Experiments) guidelines [50]. A MIQE
checklist is found in Additional file 1.
Whole-mount in situ hybridization
For whole-mount in situ hybridization (WISH), abcb4
cDNA fragments were amplified (for primers refer to
Additional file 1: Table S7), cloned into pCRII (Invitrogen)
and verified by sequencing. WISH with 18, 38 and 120 hpf
(functional proof of the used probes, specific staining in
the intestine, see Additional file 1: Figure S3) zebrafish
embryos was performed as described previously [51].
WISH staining was analyzed with a stereomicroscope
(MZ16F, Leica, Wetzlar, Germany).
Procedure for measuring efflux transporter protein
activity in zebrafish embryos with fluorescent dyes
Fluorescent dyes, rhodamine B [22,52], calcein-am
[53,54] and bodipy-vinblastine [55], served as proxies for
efflux transporter activity in the fish embryos. When this
activity is absent due to pharmacologic transporter in-
hibition or the absence of functional protein due to
morpholino knock-down, accumulation of dye in the
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cence signal. Solutions for exposures were prepared in
zebrafish embryo culture water with 0.5 μM rhodamine B,
1 μM calcein-am and 1 μM bodipy-vinblastine and inhibi-
tors cyclosporin A (CsA), PSC833 and MK571, respectively.
Up to 10 embryos per mL were incubated in the test solu-
tions for one hour at 26°C in the dark, rinsed three times
with clean culture water to remove dye from the chorion
and subsequently photographed with a fluorescence micro-
scope DMI 4000B (Leica) and DFC 350 FX camera (Leica).
For quantification of RhB dye uptake, 10 embryos per treat-
ment were sonicated in 200 μL of a hypotonic lysis buffer
(10 mM KCl, 1.5 mM MgCl2, 10 mM Tris HCl, pH 7.4),
the sonicates were briefly centrifuged, 150 μL of the super-
natant were transferred to a black 96-well microplate
(Nunc, Sigma-Aldrich, Schnelldorf, Germany) and the
rhodamine B fluorescence was measured at 595 nm (emis-
sion)/530 nm (excitation) in a GENios plus fluorescence
plate reader (Tecan, Männedorf, Switzerland). This assay
enabled parallel examination of multiple treatments. Tripli-
cates of five treatments along with a solvent control were
run per experiment. Each experiment was repeated with
embryos from three different egg batches laid on different
days. The amount of rhodamine B accumulated in zebrafish
embryos was quantified with a rhodamine B standard curve
(Additional file 1: Figure S4).
Embryo toxicity experiments
For determining toxicities of vinblastine, vincristine and
doxorubicin, 20 embryos were incubated in glass petri
dishes with 10 mL test solutions and two to three repli-
cates per treatment. Exposures to phenanthrene were set
up in tightly closed glass vials containing 2 mL solution
with four embryos per vial according to Schreiber et al.
[56] to prevent volatilization of phenanthrene from the
test solutions. Per tested treatment, five vials were set up
in parallel. Exposures were started with 4- to 16-cell
stage embryos to assure successful fertilization and ter-
minated after 48 hours. Exposure experiments were re-
peated with at least three batches of embryos from
different days. During exposure, embryos were regularly
examined using a stereo microscope and dead embryos
were removed and recorded. A final mortality count was
performed at 48 hours and embryos were declared as
dead if at least one of the following criteria applied: i)
coagulation of eggs, ii) no heart beat, iii) no blood circu-
lation, iv) no somites, v) tail not detached [45]. Initially,
toxic concentration ranges of vinblastine, vincristine,
doxorubicin and phenanthrene and the transporter in-
hibitors CsA and PSC833 were identified. Subsequently,
effects of transporter inhibitors at non-toxic concentra-
tions and, in the case of vinblastine, of morpholino
knock-down of Abcb4 and Abcb5 on the sensitivity of
the embryos to toxic test compounds were determined.Controls contained i) 0.2% DMSO used as solvent, ii) in-
hibitors only or iii) morpholino knock-down embryos
only. Mean mortality percentages and standard devia-
tions at 48 hpf were calculated from all experimental
replicates and the paired t-test was applied to determine
whether inhibitors or morpholino knock-down signifi-
cantly modulated vinblastine sensitivity of embryos.
Production of recombinant zebrafish Abcb4 protein with
the baculovirus expression system and ATPase activity
measurements
The zebrafish abcb4 cDNA was sub-cloned into pFastBac1
(Invitrogen) and sequenced for confirmation. Abcb4
baculovirus was generated using the Bac-to-Bac Baculo-
virus Expression System (Invitrogen). Sf9 cells cultured in
Sf-900 II SFM (Invitrogen) were used for virus amplifica-
tion and protein expression. Crude Sf9 membranes with
Abcb4 protein were prepared 60 hours after infection
according to [57] and then stored at −80°C until use. Total
protein in the membrane preparations was quantified using
the bicinchoninic acid assay (BCA) and bovine serum albu-
min (BSA) as standard and the presence of Abcb4 protein
in the membranes was checked in 1 μg of total protein by
Western blotting using the anti-MDR1 antibody C219
(Additional file 1: Figure S5) as described previously [58].
ATPase assays were performed as described in [37] with
minor modifications. Instead of 37°C, incubations of the
membranes with the test compounds were performed for
40 minutes at 27°C, which is within the physiological
temperature range of zebrafish. A total of 20 μg of protein
was used for each reaction. The ATPase stimulating effect
of verapamil, a classical stimulating agent of the mamma-
lian Abcb1 ATPase, was also detected for zebrafish Abcb4
(Figures 5A) and 40 μM verapamil were used as positive
control in ATPase stimulation assays and as ATPase
stimulating agent in the ATPase inhibition assays. DMSO
was used as the solvent for all compounds. The final
DMSO concentration in the reaction was 2%, which did
not affect ATPase activities.
Abcb4 and Abcb5 knock-down by morpholino (MO)
microinjection
Embryos were injected (FemtoJet, Eppendorf, Hauppauge,
USA) through the chorion into the yolk compartment at the
two-cell stage. Injection needles were pulled from borosili-
cate glass capillary tubes with filament (Warner Instruments,
Hamden, USA) using a micropipette puller (Narishige,
Tokyo, Japan).
Morpholinos (Gene Tools, Philomath, USA) were
dissolved in MilliQ water and injected at the following con-
centration ranges: 0.5 mM to 2 mM Abcb4-MO-SP (SP =
splice-blocking) (5′-AAT CTA ACT GCA TGA CGT ACT
CTG T-3′); 0.0625 mM to 1 mM Abcb4-ATG-MO (trans-
lation-blocking) (5′-GCA AAC ATG GGC AAG AAA
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GCA ACA GGT ACA TTC ATG TCT TTC T-3′) and 1
mM to 2 mM control splice morpholino (ctrl-MO) (MO
against human beta-globin) (5′- CCT CTT ACC TCA
GTTACA ATT TATA-3′). Functionality of Abcb4-SP-MO
and Abcb5-SP-MO morpholinos were proven by means
of RT-PCR (Additional file 1: Figure S6) and Abcb4-
ATG-MO morpholino with co-injected Abcb4-ATG-GFP
mRNA (Additional file 1: Figure S6). Injected embryos
were cultured for ≤48 h and transporter activity dye assays
and toxicity experiments were done as described above.
Endnotes
aOur designation of gene and protein names is based on
the Zebrafish Nomenclature Guidelines [59]; fish: shh/
Shh, human: SHH/SHH, mouse: Shh/SHH (gene/protein).
Additional file
Additional file 1: Additional information regarding the qPCR
analysis procedure: MIQE (Minimum Information for Publication of
Quantitative Real-Time PCR Experiments) checklist. Table S1 with
percent similarity data from sequence comparisons. The table is
supplementary to Figure 1B. Table S2 with the accession nos. of
sequences used for phylogenetic analyses. The table is supplementary to
Figure 1B. Table S3 with RhB amounts that had accumulated in 1, 6, 12,
24 and 48 hpf zebrafish embryos upon co-exposure to various
compounds. The table is supplementary to Figures 4 and 6. Table S4
with values from concentration-effect curves determined in zebrafish
embryo toxicity experiments. The table is supplementary to Figure 7.
Table S5 with sequences of primers used for qPCR. The table is
supplementary to Table 1. Table S6 with efficiencies of zebrafish abcb4,
abcb5 and housekeeping primers used in qPCR reactions. The table is
supplementary to Table 1. Table S7 with primer pairs used for PCR of
zebrafish abcb4 fragments used for generating probes for whole-mount
in situ hybridization (WISH). The table is supplementary to Figure 2.
Figure S1 with conserved synteny of abcb1/ABCB1 and abcb4/ABCB4
regions in various species. Figure S2 with Ct values determined for
housekeeping gene candidates in different embryo stages of zebrafish
with qPCR. The figure is supplementary to Table 1. Figure S3 with
images of 120 hpf zebrafish embryos with abcb4 mRNA transcripts
visualized using WISH. The figure is supplementary to Figure 2. Figure S4
with a standard curve used to determine the amount of RhB taken up by
zebrafish embryos. The figure is supplementary to Figures 4 and 6.
Figure S5 with images of Western blots with recombinant zebrafish
Abcb4 protein obtained with the baculovirus expression system.
Figure S6 with results of experiments proving the functionality of the
used morpholinos.
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